ZS Whitepapers, Videos and Case Studies

Why there is a significant opportunity to optimize medtech pricing and contracting practices?

Video

There is a significant opportunity within the medtech industry to optimize their pricing and contracting practices. ZS’s Medical Products and Services leader, Ganesh Vedarajan, discusses why.

Are there any disruptive forces that medtech companies should keep an eye on?

Video

ZS’s Medical Products and Services leader, Ganesh Vedarajan, shares how medtech companies can respond to uncertainty.

What three “no regret” moves should medtech companies make today?

Video

ZS Principals Ganesh Vedarajan and Kelly Tousi discuss the 3 “no regret” moves that medtech companies should make today to prepare for an uncertain future.

What opportunities exist for medtech companies to optimize SG&A today?

Video

ZS Principal Kelly Tousi discusses opportunities that medtech companies can leverage today to optimize their SG&A.

Comparing the medtech customer’s evolution to a paradox from a Greek philosopher is an apt analogy

Video

ZS’s Sudhanshu Bhatnagar shares why comparing the medtech customer’s evolution to a paradox from Zeno, a Greek philosopher, an apt analogy.

Do medtech companies really have the data to make an investment in analytics worthwhile?

Video

Business leaders in medtech see value in analytics but many are skeptical if they have the data that makes an investment in analytics worthwhile. ZS Principal Kelly Tousi weighs in.

Creating Forward Momentum

Article

How can we fund the investments required for the future while the profitability of our existing businesses is under serious pressure?

What Are the Next Moves When Checkpoint Inhibitors Fail?

Blogs

While the potential of immune-checkpoint inhibitors grabs headlines, we hear little about the patients who’ve developed resistance to these new cancer treatments. ZS’s Vikas Verma explains why this space needs more “disease leaders” and a greater emphasis on meaningful patient experiences.

Unlocking the Secret of Patient Centricity: What Does it Take for Life Sciences Teams to be More Patient Centric?

Video

In this video, get expert tips on how life sciences companies can become more patient-centric.

Behavioral Insights for a Hungry Healthcare Market

Whitepaper

This whitepaper provides evidence based insights from the ZS research study on applying behavioral science to achieve better marketing and better patient outcomes.

Growing Pains

Article

Read this article to learn critical steps industrial product manufacturers and distributors can take to accelerate customer acquisition.

Decoding How Stakeholders Drive Biosimilar Adoption

Blogs

How can biosimilars differentiate themselves when clinical differentiation isn’t possible? Here are eight key market research considerations to ensure a successful biosimilar launch.

How organizations are taking a holistic approach to growth via commercial effectiveness

Article

Learn why companies that take a comprehensive look at their business, and then make all the adjustments necessary, can improve their performance by 9% on average. Companies that do it well can improve their performance by more than 20%.